On Invalid Date, Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 2023 earnings per share (EPS) of -$0.48, up 71.43% year over year. Total Adaptive Biotechnologies earnings for the quarter were -$69.44 million. In the same quarter last year, Adaptive Biotechnologies's earnings per share (EPS) was -$0.28.
As of Q2 2024, Adaptive Biotechnologies's earnings has grown year over year. Adaptive Biotechnologies's earnings in the past year totalled -$225.25 million.
What is ADPT's earnings date?
Adaptive Biotechnologies's earnings date is Invalid Date. Add ADPT to your watchlist to be reminded of ADPT's next earnings announcement.
What was ADPT's revenue last quarter?
On Invalid Date, Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 2023 revenue of $45.78 million up 17.05% year over year. In the same quarter last year, Adaptive Biotechnologies's revenue was $55.20 million.
What was ADPT's revenue growth in the past year?
As of Q2 2024, Adaptive Biotechnologies's revenue has grown -8.11% year over year. This is 156.52 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Adaptive Biotechnologies's revenue in the past year totalled $170.28 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.